New classification for identifying HR myeloma based on cytogenetic abnormalities
Dr Cole presents, at a press conference at ASH 2015, results from a study looking at a genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia.
Read the news story and watch the video interview for more information.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
Encouraging results using mismatched unrelated donors in stem cell transplantation
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Genomic testing: Awareness and effective communication between healthcare professionals and patients